TURNATURI, RITA
 Distribuzione geografica
Continente #
AS - Asia 1.113
NA - Nord America 799
EU - Europa 489
SA - Sud America 191
AF - Africa 34
OC - Oceania 2
Totale 2.628
Nazione #
US - Stati Uniti d'America 752
SG - Singapore 411
CN - Cina 255
IT - Italia 208
BR - Brasile 151
HK - Hong Kong 113
VN - Vietnam 111
NL - Olanda 84
FR - Francia 58
KR - Corea 57
JP - Giappone 54
IN - India 36
FI - Finlandia 30
GB - Regno Unito 28
DE - Germania 26
CA - Canada 25
BD - Bangladesh 20
AR - Argentina 15
PL - Polonia 13
ZA - Sudafrica 13
MX - Messico 11
ID - Indonesia 10
IL - Israele 8
EC - Ecuador 7
ES - Italia 7
PK - Pakistan 7
AT - Austria 5
TR - Turchia 5
CL - Cile 4
CO - Colombia 4
IE - Irlanda 4
JM - Giamaica 4
PH - Filippine 4
VE - Venezuela 4
DZ - Algeria 3
IQ - Iraq 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
SA - Arabia Saudita 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
IR - Iran 2
LK - Sri Lanka 2
MT - Malta 2
PE - Perù 2
RU - Federazione Russa 2
TN - Tunisia 2
UA - Ucraina 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CV - Capo Verde 1
DJ - Gibuti 1
DM - Dominica 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
TL - Timor Orientale 1
TM - Turkmenistan 1
TW - Taiwan 1
TZ - Tanzania 1
UG - Uganda 1
UY - Uruguay 1
YT - Mayotte 1
Totale 2.628
Città #
Singapore 250
Santa Clara 163
San Jose 124
Hefei 117
Hong Kong 110
Ashburn 80
Seoul 55
Lauterbourg 49
Beijing 47
Tokyo 44
Los Angeles 41
Ho Chi Minh City 30
Hanoi 26
Dallas 25
Boardman 21
New York 19
São Paulo 18
Milan 16
Rome 15
Lappeenranta 14
Mumbai 12
West Jordan 11
Bologna 10
Cavallino 10
Council Bluffs 10
Helsinki 10
Montreal 10
Catania 9
Warsaw 9
Frankfurt am Main 8
Johannesburg 8
Messina 8
Minamishinagawa 8
Naples 8
Atlanta 7
Da Nang 7
Haiphong 7
Houston 7
Rio de Janeiro 7
Bergamo 6
Falkenstein 6
Munich 6
Poplar 6
Turku 6
Amsterdam 5
Buffalo 5
Chicago 5
Mexico City 5
Orem 5
Santo André 5
Denver 4
Pescara 4
Seattle 4
Vienna 4
Ankara 3
Belém 3
Brasília 3
Calgary 3
Caracas 3
Charlotte 3
Chennai 3
Cheyenne 3
City of London 3
Columbus 3
Dublin 3
Guangzhou 3
Guwahati 3
Hưng Yên 3
Karachi 3
London 3
Manchester 3
Marseille 3
Medellín 3
Miami 3
New Delhi 3
Phoenix 3
Quito 3
San Antonio 3
Sete Lagoas 3
Stockholm 3
Acerra 2
Andradas 2
Arvin 2
Belo Horizonte 2
Bengaluru 2
Blumenau 2
Bobrowiec 2
Boston 2
Brooklyn 2
Bảo Lộc 2
Caledonia 2
Can Tho 2
Cercola 2
Charlottesville 2
Colombo 2
Curitiba 2
Düsseldorf 2
Edison 2
Extrema 2
Feira de Santana 2
Totale 1.624
Nome #
Chimica Farmaceutica. Capitolo 26: Analgesici oppioidi. 132
Sensing B-amyloid with amphiphilic cyclodextrin/GO/KLVFF nanohybrid 113
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain 102
KLVFF@Amphiphilic Cyclodextrin/GO Nanohybrids for β-amyloid Sensing 92
KLVFF Functionalized Graphene Oxide for Aβ42 Peptide Electrical Detection: A Promising Nanomaterial for the Development of Alzheimer's Disease Diagnostic Devices 88
37th European Peptide Symposium-14th International Peptide Symposium 87
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia 83
An integrable sensoristic platform for β-amyloid based on supramolecular interactions 82
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 80
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 75
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 74
The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment 69
A carboxyethyl-β-cyclodextrin polymer and a defensin derived peptide complex with wound healing potential 64
From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design 62
Intercellular communication and ion channels in neuropathic pain chronicization 62
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 59
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 58
Multitarget opioid ligands in pain relief: New players in an old game 51
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 47
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 45
Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles 43
Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain 43
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents (vol 64, pg 11597, 2021) 41
From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design 40
In Vitro Antioxidant Activity and In Vivo Topical Efficacy of Lipid Nanoparticles Co-Loading Idebenone and Tocopheryl Acetate 38
Design, synthesis, in vitro evaluation, and molecular modeling studies of N- substituted benzomorphans, analogs of LP2, as novel MOR ligands 37
Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation 37
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 35
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 35
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review 35
(+)-and (-)-Phenazocine enantiomers: Evaluation of their dual opioid agonist/?1 antagonist properties and antinociceptive effects 35
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review 35
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling 34
Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity 34
Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy 34
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands 34
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 33
Lp1 and lp2: Dual‐target mopr/dopr ligands as drug candidates for persistent pain relief 33
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 32
Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells 32
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management 31
Progress in the development of more effective and safer analgesics for pain management 31
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 31
A Structure- and Ligand-Based Virtual Screening of a Database of ``Small'' Marine Natural Products for the Identification of ``Blue'' Sigma-2 Receptor Ligands 30
Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand 29
Antiproliferative and Antioxidant Activity of Glycoconjugates of Dithiocarbamates and Their Copper(II) and Zinc(II) Complexes 29
In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations 29
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 28
Tuning Properties for Blood-Brain Barrier Permeation: A Statistics-Based Analysis 28
Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent against Uveal Melanoma 27
Solid lipid nanoparticles as carriers for the synthetic opioid lp2: Characterization and in vitro release 27
Development of novel LP1-based analogues with enhanced delta opioid receptor profile 27
Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent sigma-1 receptor antagonist 26
Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model 25
Repeated activation of delta opioid receptors counteracts nerve injury-induced TNF-? up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opioid receptors-mediated antiallodinic effect 25
Resveratrol-Loaded Lipid Nanocarriers: Correlation between In Vitro Occlusion Factor and In Vivo Skin Hydrating Effect 25
Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: Synthesis, in silico, and biological evaluation 24
Evaluation of N-substituent structural variations in opioid receptor profile of LP1 23
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain 23
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists 20
null 12
Structural Characterization, β‐Cyclodextrin Polymer Interaction, and Biological Assessment of the N‐Terminal Peptide from the RPD‐1 Big Defensin of Ruditapesphilippinarum 10
Totale 2.805
Categoria #
all - tutte 8.658
article - articoli 7.514
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 206
Totale 16.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 4 11 1 19
2024/20251.101 19 3 54 24 178 150 23 72 30 78 254 216
2025/20261.632 123 127 121 277 258 75 246 55 112 133 60 45
2026/202737 37 0 0 0 0 0 0 0 0 0 0 0
Totale 2.805